Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1982-12-09
1985-07-02
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 69, C07D45706, A61K 3148
Patent
active
045268924
ABSTRACT:
Novel ergoline derivatives formed by reaction of an 8-carboxy ergoline with a carbodiimide and having hypotensive and antiprolatinic activity.
REFERENCES:
patent: 3245996 (1966-04-01), Hoffmann et al.
patent: 3821226 (1974-06-01), Fehr et al.
patent: 3904634 (1975-09-01), Arari et al.
patent: 4176182 (1979-11-01), Ferrari et al.
patent: 4180581 (1979-12-01), Stadler et al.
patent: 4202979 (1980-05-01), Kornfeld et al.
patent: 4219556 (1980-08-01), Hauth et al.
Bernardi, et al., "Derivati Della D.6-metil-8.beta.-aminometil-10.alpha.-ergoline", Gazz Chem. Ital. 94, 936-978 (1964).
Bosisio Germano
Caravaggi Anna M.
Di Salle Enrico
Salvati Patricia
Sapini Osvaldo
Daus Donald G.
Farmitalia Carlo Erba S.p.A.
Hendricks G.
LandOfFree
Dimethylaminoalkyl-3-(ergoline-8'.beta.carbonyl)-ureas does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dimethylaminoalkyl-3-(ergoline-8'.beta.carbonyl)-ureas, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dimethylaminoalkyl-3-(ergoline-8'.beta.carbonyl)-ureas will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-381736